Pharmacists in Worland, WY Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Dr. Rory Smith, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 Big Horn Ave, Worland, WY 82401 Phone: 307-347-2281 Fax: 307-347-3736 |
 Dr. Michelle Carol Hamilton, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 S 15th St, Worland, WY 82401 Phone: 307-347-6972 Fax: 307-347-6914 |
Mr. David Bruce Robertson, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 S 20th St, Worland, WY 82401 Phone: 307-347-2851 |
David Manasseh Ahlstrom, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 S 20th St, Worland, WY 82401 Phone: 307-347-2851 Fax: 307-347-2651 |
News Archive
STS presents Earl Bakken Scientific Achievement Award to Stanford University professor
The Society of Thoracic Surgeons presented the Earl Bakken Scientific Achievement Award to D. Craig Miller, MD on Tuesday morning during the General Session at the STS 49th Annual Meeting.
Nominations open for 2010 Health Care Stars! Awards
The second annual Health Care Stars! Awards will recognize significant contributions in positively impacting consumers and health care quality. URAC, the nation's leading health care accreditation organization, today announced that nominations are open for the awards which will be presented at the 11th Annual Quality Summit being held October 5-7, 2010 in Chicago, IL.
AEDs do not improve rate of survival for in-hospital cardiac arrests
While automated external defibrillators improve survival for out-of-hospital cardiac arrest, an analysis of data indicates their use for cardiac arrest in a hospital does not result in an improved rate of survival, according to a study in the November 17 issue of JAMA. The study is being released early online because it will be presented at the American Heart Association's annual meeting.
Mask wearing, social distancing considerably reduce incidence of many diseases
Measures to reduce the spread of COVID-19 through non-pharmaceutical interventions (NPIs) such as mask wearing and social distancing are a key tool in combatting the impact of the ongoing coronavirus pandemic.
Drug companies collaborate with DNDi support to develop drug for African sleeping sickness
Researchers from Scynexis Inc. of Research Triangle Park, N.C., and Anacor Pharmaceuticals in Palo Alto, Calif., sponsored by the Drugs for Neglected Diseases initiative, on Tuesday reported in the journal PLoS Neglected Tropical Diseases that a new experimental drug kills the parasite that causes African sleeping sickness in mice and will enter human clinical trials this year, ScienceNOW reports.
› Verified 3 days ago
Counselors
Dentists
Clinical Social Workers
Occupational Therapists
Pharmacists
Psychologists